Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCOG: Rivaroxaban vs Warfarin on Cognition
NCT04073316Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Feb 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04073316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04073316.